The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $1.39

Today's change0.00 -0.14%
Updated December 8 12:56 PM EST. Delayed by at least 15 minutes.
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $1.39

Today's change0.00 -0.14%
Updated December 8 12:56 PM EST. Delayed by at least 15 minutes.

Reversal following new 100-day high

VIVUS Inc is lower today, dropping (U.S.)$0.00 or 0.14% to (U.S.)$1.39 after setting a new 100-day high. Shares have lost 1.56% over the last five days, but have gained 36.08% over the last year to date. This security has outperformed the S&P 500 by 33.00% during the last year.

Key company metrics

  • Open(U.S.) $1.39
  • Previous close(U.S.) $1.39
  • High(U.S.) $1.40
  • Low(U.S.) $1.36
  • Bid / Ask(U.S.) $1.38 / (U.S.) $1.39
  • YTD % change+36.08%
  • Volume115,986
  • Average volume (10-day)730,490
  • Average volume (1-month)566,791
  • Average volume (3-month)431,627
  • 52-week range(U.S.) $0.92 to (U.S.) $1.85
  • Beta1.41
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.44
Updated December 8 12:56 PM EST. Delayed by at least 15 minutes.
S&P TSX0.35%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue13141515
Total other revenue--------
Total revenue13141515
Gross profit11111213
Total cost of revenue2343
Total operating expense14172020
Selling / general / administrative10141514
Research & development2113
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0--0
Other operating expenses, total--------
Operating income-1-4-5-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-11-13-12
Income after tax-9-11-13-12
Income tax, total0000
Net income-9-11-13-12
Total adjustments to net income--------
Net income before extra. items-9-11-13-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-11-13-12
Inc. avail. to common incl. extra. items-9-11-13-12
Diluted net income-9-11-13-12
Dilution adjustment--0----
Diluted weighted average shares104104104104
Diluted EPS excluding extraordinary itemsvalue per share-0.09-0.11-0.12-0.12
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.09-0.11-0.12-0.12